The invention relates to a reduction responsiveness nanoscale
graphene oxide coated
medicine carrying mesoporous
silicon dioxide nano particle and a preparation method thereof. The reduction responsiveness nanoscale
graphene oxide coated
medicine carrying mesoporous
silicon dioxide nano particle consists of mesoporous
silicon dioxide nano particles and nanoscale
graphene oxide, wherein the mesoporous
silicon dioxide nano particles are modified by a compound which simultaneously contains a
disulfide bond, an amino group and carboxyl and can load medicines, and the nanoscale graphene oxide coats the mesoporous
silicon dioxide nano particles. The preparation method comprises the following steps: adding the mesoporous
silicon dioxide nano particles which are modified by the compound which simultaneously contains the
disulfide bond, the amino group and the carboxyl and can load medicines into carboxyl activated nanoscale graphene oxide
aqueous solution, stirring at
room temperature to generate amidation reaction, carrying out centrifugal washing, and carrying out
freeze drying to obtain a
medicine controlled release material which is modified by the nanoscale graphene oxide and has reduction responsiveness. The
carrier material of the invention has good
biocompatibility and high medicine loading capacity, and the
controlled release of the medicine can be realized by the reduction responsiveness of the
disulfide bond, the medicine hardly releases around normal cells but quickly releases under the microenvironment of tumor
cell reduction, and the nano particle has important
physiological significance and research value.